Pharmacokinetic study of fixed dose combination of aclidinium bromide/ formoterol versus either of monotherapies (aclidinium or formoterol) in healthy volunteers

Trial Profile

Pharmacokinetic study of fixed dose combination of aclidinium bromide/ formoterol versus either of monotherapies (aclidinium or formoterol) in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Apr 2016

At a glance

  • Drugs Aclidinium bromide/formoterol (Primary) ; Aclidinium bromide; Formoterol
  • Indications Chronic obstructive pulmonary disease
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 06 Apr 2016 New trial record
    • 01 Mar 2016 Results published in the Clinical Pharmacology in Drug Development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top